Elliott F Winton MD

School/Division:

Other Affiliations:

No affiliations have been saved.

External Links (e.g. Departmental web site, iTunes lectures, etc.):

No external links have been saved.

Degrees Held:

No degrees have been saved.

Research Interests:

No research interests have been saved.

Biography/Description of Research:

No biography information has been saved.

Works 1-10 of 18

  1. 1
  2. 2

Article

Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study

by Elliott Winton; CN Harrison; N Schaap; AM Vannucchi; J-J Kiladjian; RV Tiu; P Zachee; E Jourdan; RT Silver; HC Schouten; F Passamonti; S Zweegman; M Talpaz; J Lager; Z Shun; RA Mesa

2017

Article

A randomized phase 3 trial of interferon-alpha vs hydroxyurea in polycythemia vera and essential thrombocythemia

by Elliott Winton; J Mascarenhas; HE Kosiorek; JT Prchal; A Rambaldi; D Berenzon; A Yacoub; CN Harrison; MF McMullin; AM Vannucchi; J Ewing; CL O'Connell; J-J Kiladjian; AJ Mead; DS Leibowitz; V De Stefano; MO Arcasoy; CM Kessler; R Catchatourian; D Rondelli; RT Silver; A Bacigalupo; A Nagler; M Kremyanskaya; MF Levine; JEA Ossa; E McGovern; L Sandy; ME Salama; V Najfeld; J Tripodi; N Farnoud; A Penson; RS Weinberg; L Price; JD Goldberg; T Barbui; R Marchioli; G Tognoni; RK Rampal; RA Mesa; AC Dueck; R Hoffman

2022

Article

Safety and efficacy of avapritinib in advanced systemic mastocytosis: the phase 1 EXPLORER trial

by Elliott Winton; DJ DeAngelo; DH Radia; T George; WA Robinson; AT Quiery; MW Drummond; P Bose; EO Hexner; H-P Horny; M Tugnait; O Schmidt-Kittler; EK Evans; H-M Lin; BG Mar; S Verstovsek; MW Deininger; J Gotlib

2021

Article

Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia

by Morgan McLemore; Elliott Winton; Amelia Langston; Leonard Heffner Jr.; Manila Gaddh; Martha Arellano; Vamsi Kota; AP Jillella; LT Heffner; C Zhang; CR Caprara; KS Simon; SL Bolds; S DeBragga; P Karkhanis; SH Krishnamurthy; J Tongol; MM El Geneidy; A Pati; JM Gerber; MR Grunwald; J Cortes; A Bashey; RK Stuart

2021

Article

Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera

by Elliott Winton; A Coltoff; R Mesa; J Gotlib; J Shulman; RK Rampal; O Siwoski; A Yacoub; A Moliterno; A Yang; E Braunstein; AT Gerds; GS Hobbs; S Goel; M Wadleigh; D Tremblay; E Moshier; J Mascarenhas

2020

Article

Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis.

by John O. Mascarenhas; Moshe Talpaz; Vikas Gupta; Lynda M. Foltz; Michael R. Savona; Ronald Paquette; A. Robert Turner; Paul Coughlin; Elliott Winton; Timothy C. Burn; Peter O'Neill; Jason Clark; Deborah Hunter; Albert Assad; Ronald Hoffman; Srdan Verstovsek

2017

Article

Effect of Ruxolitinib Therapy on Myelofibrosis-Related Symptoms and Other Patient-Reported Outcomes in COMFORT-I: A Randomized, Double-Blind, Placebo-Controlled Trial

by Ruben A. Mesa; Jason Gotlib; Vikas Gupta; John V. Catalano; Michael W. Deininger; Alan L. Shields; Carole B. Miller; Richard T. Silver; Moshe Talpaz; Elliott Winton; Jimmie H. Harvey; Thomas Hare; Susan Erickson-Viitanen; William Sun; Victor Sandor; Richard S. Levy; Hagop M. Kantarjian; Srdan Verstovsek

2013

Article

The clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosis

by Srdan Verstovsek; Ruben A. Mesa; Jason Gotlib; Richard S. Levy; Vikas Gupta; John F. DiPersio; John V. Catalano; Michael Deininger; Carole Miller; Richard T. Silver; Moshe Talpaz; Elliott F Winton; Jimmie H. Harvey; Murat O. Arcasoy; Elizabeth Hexner; Roger M. Lyons; Ronald Paquette; Azra Raza; Kris Vaddi; Susan Erickson-Viitanen; William Sun; Victor Sandor; Hagop M. Kantarjian

2013

Article

SIMPLIFY-1: A Phase III Randomized Trial of Momelotinib Versus Ruxolitinib in Janus Kinase Inhibitor-Naive Patients With Myelofibrosis

by Ruben A. Mesa; Jean-Jacques Kiladjian; John V. Catalano; Timothy Devos; Miklos Egyed; Andrzei Hellmann; Donal McLornan; Kazuya Shimoda; Elliott Winton; Wei Deng; Ronald L. Dubowy; Julia D. Maltzman; Francisco Cervantes; Jason Gotlib

2017

Article

Ruxolitinib for the treatment of patients with polycythemia vera

by Jean-Jacques Kiladjian; Elliott Winton; Moshe Talpaz; Srdan Verstovsek

2015